TABLES FOR EPIDEMIOLOGISTS

  • 2 × 2 and 2 × 2 stratified tables for longitudinal, cohort study, case–control, and matched case–control data
  • Odds ratio, incidence ratio, risk ratio, risk difference, and attributable fraction
  • Confidence intervals for the above
  • Chi-squared, Fisher’s exact, and Mantel–Haenszel tests
  • Tests for homogeneity
  • Choice of weights for stratified tables: Mantel–Haenszel, standardized, or user specified
  • Exact McNemar test for matched case–control data
  • Tabulated odds and odds ratios
  • Score test for linear trend

Watch immediate commands in Stata with summary data tutorials

POWER AND SAMPLE SIZE

  • Stratified 2×2 tables (Cochran–Mantel–Haenszel test)
  • 1:M matched case–control studies
  • Trend in J×2 tables (Cochran–Armitage test)

STANDARDIZATION OF RATES

  • Direct standardization
  • Indirect standardization

GENERALIZED LINEAR MODELS FOR THE BINOMIAL FAMILY

  • Individual-level or grouped data
  • Odds ratios, risk ratios, health ratios, and risk differences
  • Bayesian estimation

ADDITIVE MODELS OF RISK

  • relative excess risk due to interaction, excess relative risks, attributable proportion, and synergy index
  • confidence intervals for the above
  • models for binary and count outcomes, and survival–time data

 

TABLE SYMMETRY AND MARGINAL HOMOGENEITY TESTS

  • n x n tables where there is one-to-one matching of cases and controls
  • Asymptotic symmetry and marginal homogeneity tests
  • Exact symmetry tests
  • Transmission disequilibrium test (TDT)

KAPPA MEASURE OF INTERRATER AGREEMENT

  • Two unique raters
  • Weights for weighting disagreements
  • Nonunique raters, variables record ratings for each rater
  • Nonunique raters, variables record frequency of ratings

TWO-WAY TABLE OF FREQUENCIES

 

BRIER SCORE DECOMPOSITION

 

U.S. FOOD AND DRUG ADMINISTRATION (FDA) SUBMITTALS

  • Read and write data in the format required by the FDA for new drug application (NDA) submittals
  • Describe the contents of data written in the FDA required format
  • Produce an Installation Qualification (IQ) report
  • Read about Stata and FDA compliance

 

© Copyright 1996–2024 StataCorp LLC. All rights reserved.

META-ANALYSIS

  • Effect sizes for binary and continuous outcomes
  • Common-effect, fixed-effects, and random-effects models
  • Forest plots, funnel plots, and more plots
  • Subgroup meta-analysis
  • Meta-regression
  • Small-study effects and publication bias
  • Cumulative meta-analysis
  • Multivariate meta-analysis
  • And more

RECEIVER OPERATING CHARACTERISTIC (ROC) ANALYSIS 

  • Fit ROC regression models, with covariates
  • Calculate area under the curve
  • Calculate partial area under the curve
  • Obtain sensitivity for a given specificity, and vice versa
  • Test equality of ROC area against a “gold standard”
  • Šidák adjustment for multiple comparisons
  • Easy ROC curve plots for different classifiers and covariate values
  • ROC curve with simultaneous confidence bands

ICD-10 AND ICD-9 CODES

  • Designed for use with
    • The US National Center for Health Statistics (NCHS) ICD-10-CM diagnosis codes for healthcare encounter and claims data
    • The US Centers for Medicare and Medicaid Services (CMS) ICD-10-PCS procedure codes for healthcare claims data
    • The World Health Organization’s ICD-10 codes for morbidity and mortality reporting
    • NCHS ICD-9-CM diagnosis codes for healthcare encounter and claims data
    • CMS ICD-9-CM procedure codes for healthcare claims data
  • Suite of commands lets you:
    • Easily generate new variables based on codes
      • Indicators for different conditions
      • Short descriptions
      • Category codes from billable codes
      • And more
    • Verify that a variable contains valid codes and flag invalid codes
    • Standardize the format of codes
  • Interactive utilities let you
    • Look up descriptions for codes
    • Search for codes from keywords
  • ICD-10 and ICD-10-CM/PCS commands let you indicate the version of the codes in your dataset

SURVIVAL ANALYSIS

 

CAUSAL INFERENCE/TREATMENT EFFECTS

 

PHARMACOKINETICS

  • Pharmacokinetic measures from time-and-concentration subject-level data
  • Tests that measurement is normally distributed
  • Analysis of data from crossover design experiment
  • Tests of bioequivalence for two treatments
  • Nonlinear mixed-effects models
  • Multiple-dose pharmacokinetic modeling